Bioventus Inc.

NASDAQ:BVS

11.17 (USD) • At close September 13, 2024
Bedrijfsnaam Bioventus Inc.
Symbool BVS
Munteenheid USD
Prijs 11.17
Beurswaarde 728,137,662
Dividendpercentage 0%
52-weken bereik 2.821 - 11.24
Industrie Medical Devices
Sector Healthcare
CEO Mr. Anthony P. Bihl III
Website https://www.bioventus.com

An error occurred while fetching data.

Over Bioventus Inc.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its

Vergelijkbare Aandelen

Surmodics, Inc. logo

Surmodics, Inc.

SRDX

39.36 USD

BioLife Solutions, Inc. logo

BioLife Solutions, Inc.

BLFS

25.12 USD

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

COLL

37.5 USD

Humacyte, Inc. logo

Humacyte, Inc.

HUMA

5.64 USD

Castle Biosciences, Inc. logo

Castle Biosciences, Inc.

CSTL

31.18 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)